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Background
Attention-deficit/hyperactivity disorder (ADHD (MIM:143465)) affects approximately 8-12% of school-age children worldwide (Biederman and Faraone 2005) . It is typically characterized by inattention, excessive motor activity, impulsivity, and distractibility. Individuals with ADHD have significant impairment in family and peer relations. Moreover, they have difficulties in academic functioning and show high co-morbidity with a wide range of psychiatric disorders including oppositional defiant disorder (ODD), conduct disorder (CD), anxiety disorder, depression, substance abuse and pervasive developmental disorder (PDD). Four types of symptoms of CD are recognized: aggression or serious threats of harm to people or animals; deliberate property damage or destruction (e.g., fire setting, vandalism); repeated violation of household or school rules, laws, or both; and persistent lying to avoid consequences or to obtain tangible goods or privileges (American Psychiatric Association 2000) .
Family studies suggest that ADHD+CD represents a specific subtype of disorder with familial risk factors only partly overlapping with those of ADHD alone (Faraone and others 1997; Faraone and others 1991; Faraone and others 2000; Frick and others 1991; Lahey and others 1988; Stewart and others 1980; Szatmari and others 1993) . In a recent study by this group, we examined the sibling risk for probands with ADHD and conduct problems (Christiansen and others 2008) .
Families with an index case with ADHD-CT+CP (ADHD-combined type with co-morbid conduct problems) showed, when adjusted for gender and parental socioeconomic status, an increased sibling recurrence relative risk (SRRR) for both ADHD-CT (SRRR=2.9; 95%CI 1. 6-5.3, p<0.001) and ADHD-CT+CP (SRRR=4.9; 95%CI 2.6-9.4, p<0.001) compared to the population risk.
Additional factors, such as shared family environment, independent of socio-economic status, may also explain these findings. Nevertheless, putative shared familial environmental risk may serve to prime underlying genetic risk and facilitate expression of the disorder.
Individuals with the ADHD-CT+CP subtype manifest more severe symptoms of ADHD than those classified as having ADHD-CT alone. Moreover, ADHD-CT+CP may constitute a distinct familial disorder or a more extreme manifestation on an ADHD phenotypic continuum. Under both models one would predict ADHD-CT+CP would represent a more genetically loaded disorder compared to ADHD-CT alone. Family, twin, and adoption studies strongly support the influence of genetic factors on the etiology of ADHD (Biederman and Faraone 2005; Faraone and others 2005; Thapar and others 2005) . Similarly strong genetic factors have been implicated in externalizing behaviors, such as CD (Hicks and others 2004) . The influence of genetic risk in the etiology of ADHD-CT+CP has also been explored (Burt and The overlap between ADHD and ADHD+CP was explained by common genetic and common shared environment. Despite this, the environmental influence on CP would suggest that ADHD and ADHD+CP are partly distinct traits, however, ADHD-CT+CP was shown to be more genetically loaded than ADHD-CT (Thapar and others 2001) . The common genetic etiology model of ADHD and CP is also supported by Vierikko and others. In the longitudinal Finnish Twin Study, FinnTwin12, they show a strong genetic correlation between aggressive and hyperactivity-impulsivity symptoms in ADHD (Vierikko and others 2004) . Contradictory evidence for a common genetic etiology has also been described in a large sample of 11 year old twins from the Minnesota Twin Study (Burt and others 2005) . These data suggest that there is only marginal significant genetic contribution to a composite general externalizing behavior factor (Ext), generated from diagnosis of ADHD, CD or ODD. The variance in the Ext trait was best explained by the shared-environment. The examination of more homogenous common factors that link ADHD and the co-morbid disorders may enable greater understanding of the etiology of both the uniqueness and commonality of the disorders.
The Genetics of ADHD and Conduct Problems
Candidate gene association analysis has focused on genes within monoamine neurotransmitter systems, specifically those important in dopaminergic and serotonergic neurotransmission.
Meta-analyses suggest that variation in the genes that code for the dopamine receptors D4 (DRD4) and D5 (DRD5), the 5-hydroxytryptamine (serotonin) transporter (SLC6A4), the serotonin 1B receptor (HTR1B), synaptosomal protein of 25kD (SNAP25) and the dopamine transporter (SLC6A3) influence susceptibility to ADHD (Faraone and others 2005) . The genetics of antisocial externalizing behaviors has also focused on monoamine neurotransmitter systems, specifically serotonergic neurotransmission. Recent studies have identified modest association signals in the HTTLPR polymorphism of SLC6A4 (Sakai and others 2006) and a putatively functional polymorphism (RS4680) in the Catechol-O-Methyltransferase (COMT) gene (Caspi and others 2008) . A linkage study in the Collaborative Study of the Genetics of Alcoholism (COGA) provides suggestive evidence that regions on chromosome 19 (D19S714; LOD score=2.82, NCBI Build36 location Chr19; 15589133 to 15589407) and chromosome 2 (D2S1331; LOD score=2.40, NCBI Build36 location Chr2; 86436445 to 86436847) may harbor susceptibility gene for conduct disorder (Dick and others 2004) .
Candidate gene association studies have examined genes involved in monoaminergic neurotransmission for association with CD in an ADHD population [e.g. (Beitchman and others 2003; Comings and others 2000a; Comings and others 2000b) ]. None of these studies have found strong evidence for association with the trait. To date, no linkage or genome-wide association study (GWAS) has examined the role of conduct problems in the ADHD population.
The Genetic Association Information Network
The Genetics Analysis Information Network (GAIN) is a public-private partnership between the NIH the private sector with the goal of promoting GWAS for various complex diseases (http://www.fnih.org/GAIN2/home_new.shtml). Nine hundred and fifty eight ADHD-parent trios from the International Multicenter ADHD Genetics Project (IMAGE) were genotyped as part of the GAIN initiative. We recently reported the initial findings of the IMAGE GWAS sample using a DSM-IV diagnosis of ADHD type in a family based association analysis (Neale and others 2008) .
These findings report no genome-wide significant associations according to the criteria suggested by Dudbridge and others (Dudbridge and Gusnanto 2008) . It is possible that phenotypic and genetic heterogeneity may explain, in part, the lack of genome-wide significant findings in this dataset.
The comorbidity of CP in ADHD is readily examined in the IMAGE dataset as measurements of CP was made during the assessment process. Specifically, the ADHD diagnostic tools measure behavior including violence and cruelty to others, theft and vandalism and opposition to socially accepted behaviors and rules such as truancy and curfews. In this manuscript we use the CP symptoms to generate one categorical and two quantitative measures of CP that are used as the phenotypes of interest in GWAS analyses.
Materials and Methods

Subjects
Families were collected by the International Multicenter ADHD Genetics (IMAGE) project. IMAGE families were identified through ADHD probands aged 5 to 17 attending outpatient clinics at the data collection sites in Europe. A total of 958 affected proband-parent trios were initially selected for the GWAS scan. Family members were Caucasians of European origin from seven countries around Europe including Belgium, Germany, Ireland, the Netherlands, Spain, Switzerland, the United Kingdom and Israel. 938 probands were diagnosed as having DSM-IV combined type ADHD and 208 individuals had a DSM-IV CD diagnosis. Additional descriptive data are presented in Table 1 . 
Clinical Measures
We identified three broad phenotypic measures of conduct problems (CP) for the ADHD probands. First a categorical measure of CP was defined using DSM IV criteria of CD using a standardized algorithm applied to the Parent Account of Childhood Symptoms (PACS) (Chen and Taylor 2006; Taylor and others 1986) . Two additional quantitative measures of CP were defined using the PACS and the Long Version of the Conners Parent Rating Scale (CPRS-R:L) (Conners and others 1998) , where the PACS collected CP symptom information and the CPRS-R:L gathered the symptom on a less severe behavioral characteristic of an oppositional defiant individual. The CPRS-R:L and PACS were administered to the parents of the affected child by investigators at each center. There was centralized training for all who administered either the CPRS-R:L or the PACS and the responses to questions were standardized. The PACS assesses the following CPrelated symptoms on a 5-point ordinal scale: 1) bully; 2) start fights; 3) used weapon; 4) cruel to animals; 5) cruel to people; 6) stay out at night; 7) tried to set fire to something; 8) run away from home; 9) broken into a building or car; 10) truanted from school; 11) threatened anyone with a gun; 12) mugging, extortion, robbery; 13) forced someone into sexual activity; 14) stealing frequency; 15) destructiveness frequency; 16) destructiveness severity; 17) aggressiveness frequency; and 18) aggressiveness severity. The 5-point scale has the following levels: 0 = never; 1= occasionally in the last 6 months; 2= frequently in the last 6 months; 3 = present in the last 7-12 months, 4 = present more than 12 months ago. Because the distribution of responses to each symptom was bimodal, indicating that the child exhibits/does not exhibit the symptom, the responses were dichotomized and then summed. The CPRS-R:L collected symptom information that was on the CP-continuum, but more likely gives a better representation of a child with ODD.
The variables were also measured on a 4-point ordinal scale and the responses were spread more evenly through the four categories. Therefore the variables were kept as is and summed.
The measures included: 1) angry and resentful; 2) argues with adults; 3) loses temper; 4) irritable; 5) actively defies or refuses to comply with adults' requests; 6) temper outbursts; 7) touchy or easily annoyed by others; 8) blames other for his/her mistakes or misbehavior; 9) disturbs other children; 10) deliberately does things that annoy other people; 11) demands must be met immediately -easily frustrated; and 12) spiteful or vindictive. The 4-point scale has the following levels: 0=not true, never or seldom; 1 = just a little true, occasionally; 2 = pretty much true, often or quite a bit; 3 = very much true, very often or very frequent.
Genotyping Methodology
This study is part of the Genetic Association Information Network (GAIN), a public-private Genotype data were cleaned by The National Center for Biotechnology Information (NCBI).
Quality Control analyses were processed using the GAIN QA/QC Software Package (version 0.7.4) developed by Gonçalo Abecasis and Shyam Gopalakrishnan at the University of Michigan. A copy of the software is available by e-mailing gopalakr@umich.edu or goncalo@umich.edu. The quality control procedure for cleaning this dataset is described elsewhere (Neale and others 2008) .
Analysis was limited to a "super-clean" set of SNPs that passed the quality control metrics for two additional GAIN Perlegen studies (for Major Depression Disorder (MDD) and Psoriasis). The use of the "super-clean" SNP selection approach is premised that the individual assay may not generally perform well and may pass quality-control metrics in one but not other studies. After excluding sex-chromosomes, additional frequency and genotyping pruning, 378,332 autosomal SNPs were examined as part of this study.
Statistical Analysis FBAT
The Family-Based Association Test (FBAT) is a generalization of the TDT, which allows valid testing of association with any phenotype, sampling structure, and pattern of missing marker allele information (Horvath and others 2001; Horvath and others 2004; Lange and others 2004) .
We used Pedigree Based Association Test (PBAT) for the analyses on the three phenotypes. The dichotomous CP variable, indicating the presence or absence of CD according to DSM-IV diagnosis (American Psychiatric Association 2000) was used in FBAT analyses with an offset using the sample CD prevalence. This contrasts the genotypic information from the affected and unaffected individuals in order to identify CP disease susceptibility loci. The two quantitative phenotypes were analyzed using FBAT, while adjusting for age and gender. For all three traits we considered additive, dominant, and recessive models of inheritance. Sex chromosome markers were excluded from analysis as the FBAT/PBAT statistic is not suitable for hemizygous individuals.
Each of the nine examined phenotype and inheritance models were considered separately. All association findings are presented in the context of two evidence levels; genome-wide significance (p≤5x10-7) and strong significance (p≤1x10-5). All genotyping scatterplots for markers showing strong significance were manually examined to exclude those markers showing potential genotyping calling bias .
SNP Labeling
All cross-referencing of SNPs was performed according to dbSNP build 128 and Human Genome build 36.2. All files are available from NCBI at ftp://ftp.ncbi.nih.gov/snp/database/organism_data/ human_9606/. All SNP codes were updated to reflect dbSNP build 128 using RsMergeArch.bcp.
Chromosome location was assigned using b128_SNPChrPosOnRef_36_2.bcp. Gene links were assigned using b128_SNPContigLocusId_36_2.bcp. Functional inference of linked genes was examined using Gene Ontology (GO) terms.
Linkage Disequilibrium Expansion and Functional Cross-Referencing
Linkage Disequilibrium Expansion (LDE) is a method to identify markers that are not tested directly on the Perlegen Array, but show very strong correlation with a tested marker. By expanding the dataset to include these "proxy-SNPs" we present a more inclusive list of associated markers and more importantly provide a more inclusive framework to cross-reference association findings with previous work or genomic landmarks, such a gene loci. LDE was performed using self-authored Perl scripts. Markers that met an unadjusted P-value (P≤1x10-5) were identified and used to identify markers in near complete LD (R2≥0.98) in a 200kb window. Using the CEU HapMap data as a proxy-measure of Northern European LD structure, markers that were not on the array but met the LD criteria were identified.
Functional Cross-Referencing is a process of tagging SNPs with descriptive labels to facilitate the interpretation of the GWAS. Specifically, we tagged all associated SNPs (direct and LD expanded) with gene identifiers using the b128_SNPContigLocusId_36_2.bcp (available at http://www.ncbi.nlm.nih.gov/). Additionally, annotation of functional sites was performed by examining data from the UCSC Genome Browser (http://genome.ucsc.edu/). Specifically, we examined tracks to identify SNPs that were tagged as synonymous, non-synonymous, or located within the intron, promoter, putative transcription factor binding sites, CpG islands and regions showing conservation across species.
Analysis of whether markers within the associated regions have previously been shown to be associated with other mental health disorder was performed by cross-referencing markers and genes with the UNC Evidence Project database (https://slep.unc.edu/evidence/) (Konneker and others 2008) . The search strategy used was staged according to the location of the associated marker: if the marker was found within a gene locus, we examined evidence from linkage, association and meta-analysis that specifically cross-references with the gene location; if the marker was found in an intergenic region, we examined evidence of linkage, association and meta-analysis 50kb upstream and downstream of the marker location.
Candidate Gene Enrichment
Under the candidate gene model of association, a gene is selected based upon a prior hypothesis that this gene is likely to have role in the etiology of the trait under investigation. The GWAS approach somewhat negates the need for prior hypothesis. As no selection on genes is performed prior to analysis the GWAS approach examines all genes without favor. However, it is still of interest to examine whether genes or groups of genes that have been suggested as candidate genes for a trait show an enrichment of association signals compared to genes not under selection. To test this hypothesis we examined genes selected based on a prior hypotheses, namely that they have been linked to serotonergic neurotransmission.
LDE was applied to all markers that passed QC criteria. This expanded list of markers was then annotated with gene identifiers using b128_SNPContigLocusId_36_2.bcp. Genes associated with serotonergic neurotransmission were identified through a keyword search of the GO database through GenNav (http://mor.nlm.nih.gov/perl/gennav.pl), in addition to those genes involved in the tyramine synthesis pathway. The complete list of serotonin-related genes used in this analysis are AANAT, ALDH2, AOX1, DDC, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR3A, HTR3B, HTR4, HTR5A, HTR6, HTR7, INDOL1, INMT, SLC6A4, TPH1 and TPH2.
ATP7A, ASMT, MAOA, MAOB and HTR2C were also considered in the original gene list but could not be examined due to their presence on the X-chromosome. All markers within the serotonergic genes and 10kb 5' and 3' of the genes were compared to all other markers. Logistic regression was performed to examine whether there was significant deviation in nominally associated SNPs (P<=0.05) from the null hypothesis for the selected genes.
Results
We performed a hypothesis-free analysis of the GAIN-ADHD sample to identify markers and genes important in the development of conduct problems in a European cohort of individuals with ADHD. Using the Family-Based Association Test (FBAT) package we examined three measures of conduct problems; a categorical measure defined using DSM IV criteria for conduct disorder, and two additional quantitative measures derived from the Parent Account of Childhood Symptoms (PACS) and the Long Version of the Conners Parent Rating Scale -Revised (CPRS-R:L). Each trait was tested under dominant, additive and recessive inheritance models.
After the quality control procedures, 378,332 markers that map to dbSNP build 128 and Human Genome build 36.2 were available for analytic use. LDE of the markers to incorporate proxymarkers altered the effective number of SNPs to 1,043,963 unique markers. A total of 938 offspring were included after the cleaning process. Of these individuals, 876 offspring had complete CPRS-R:L data and 907 offspring had complete PACS information. A summary of the total sample that contributed to at least one part of the analyses presented in this paper is listed in Table 1 .
None of the markers reached genome-wide significance p≤5x10-7. Quantile-Quantile plots for each diagnosis and inheritance model indicate that there is no skew of association signals (expressed as p-value) achieved above that expected by chance alone (see Figure 1) . Across all three phenotypes there are 28 unique modest genome-wide association signals at p≤1x10-5. Following LDE this number increased to 54 markers. A summary of the association signal for each marker is given in Figure 2 below.
Fifteen markers were located in nine genes. The associated genes include A2BP1, c12orf28, FLJ39061, KIRREL3, LOC729257, PAWR, PKD1L2, PKD1L3 and RGL1. A further twenty-three genes were identified within a 200kb window around the association signal (see Table 2 ). Examination of the candidate gene enrichment using serotonin-related genes indicated that there was no signal enrichment for any of the diagnosis-inheritance groups. Conversely, there is a reduction in association signal (OR=.74; 95%CI .6-.91, p=.005) for those genes tagged as being serotonergic.
See Table 2 at the end of this report Table 2 : Summary of markers that show association signal at p≤1x10 -5 for the three diagnostic measures (categorical, quantitative CPRS-R:L and quantitative PACS) and three inheritance models (additive, dominant and recessive). Signal refers to the unique signal block from the GWAS, Freq refers to the risk allele frequency, and N refers to number of informative transmissions in the analysis for the SNP under the trait and inheritance model. ‡ Previous Association References were identified from the UNC Evidence Project database and confirmed by examination of the source material. Disease and analysis codes can be found at https://slep.unc.edu/evidence/. ◊ Markers highlighted as unknown are not found within the UCSC Genome Browser and could not be analyzed for functional landmarks.
Discussion
This study is part of a series of exploratory analyses to identify candidate genes that may be important in ADHD and ADHD-related traits, such as conduct problems. It is important to examine these data under the caveat that they are exploratory and like all association studies previous to this, these data will require independent replication. With this qualification considered, one must be cautious as to not over-or under-interpret these data.
In this analysis we did not find genome-wide statistical significance for any of the tested markers As with all GWA (and linkage) studies, we aim to achieve insight into the etiology of a trait using a hypothesis-free study design. In the absence of candidate gene bias we are able to identify potentially interesting targets for follow-up studies. We have highlighted a number of chromosome regions and genes that are on the periphery of the "psychiatric candidate gene" A number of the markers that meet strong significance (p<1x10-5) lie within regions implicated in other psychiatric traits and also harbor genes with strong candidature for these traits. It remains to be seen whether this represents true cross-trait risk or highlights the abundance of genomic regions now implicated in psychiatric disease.
To enrich the number of markers linked to genes and therefore define a more complete number of gene-tagging SNPs in this dataset we used a LDE protocol to identify proxy markers in complete linkage disequilibrium with the tested marker. We assumed that the white European sample examined in this study shows similar LD patterns to the CEPH European HapMap sample.
The test and proxy marker sets were then aligned to gene co-ordinates from build36 of the human genome project. This approach is somewhat transcript-centric and may exclude regulatory elements not captured by LD. Moreover, the FBAT/PBAT statistic is not suitable for Xlinked markers and consequently X-linked genes are excluded.
None of the genes tagged as "serotonin-related" according to our inclusion criteria achieved association signals at p≤1x10-5. The caveat for any network-based analysis is the annotation used to define the network of genes, and the methodology used to assign given markers to gene terms. GO terms, are reasonably well annotated but keywords such as serotonin may exclude genes that influence monoamines in general. Moreover, the inclusion of general keywords reduces the specificity of the network. We focused on a mixture of GO terms, KEGG annotations and evidence from the literature to tag genes as being "serotonin-related". From the markers included, a marker on chromosome 13 in the Serotonin 2A Receptor (HTR2A), RS6314 showed the strongest association (RS6314, Categorical Diagnosis of Conduct Problems (Dominant Inheritance) p=.00087).
The strongest signal from those serotonin-related genes that we have previously studied in relation to ADHD-CT in a subset of the IMAGE dataset (Brookes and others 2006) was observed for RS363052, a marker on chromosome 20 in the Synaptosomal-Associated Protein, 25kDa (SNAP25) (RS363052, Quantitative Diagnosis of Conduct Problems for CPRL (Recessive Inheritance) p=.000025). Of the notable candidate genes previously studied for their putative role in conduct problems, namely SLC6A4 and DRD4, no marker within the gene or a 10kb window upstream or downstream of the gene were found to be associated at p<1x10-2.
This study is the first to perform a hypotheses-free genome-wide association analysis of comorbid conduct problems in ADHD. By using the FBAT approach we are able to examine categorical and quantitative measures of conduct disorder as well as specific inheritance patterns. Moreover, the FBAT approach has over 75% power to detect SNPs with heritability estimates of 0.01 or more at a nominal alpha level of 0.001 using this methodology. However, we must again offer caution regarding whether ADHD+CP represents a more extreme presentation with regards to genetic burden. Moreover, these findings may not be relevant to CP in a general population but reflect risk to a clinical subtype of ADHD with CP.
This study is the first to perform a hypothesis-free genome-wide analysis of comorbid conduct problems in ADHD. As such, this study should be viewed as a hypothesis-generating study.
Consequently, strict statistical evidence is required. No markers met genome-wide significance and the distribution of association signals did not indicate any strong enrichment of association signals greater than expected by chance alone. However, we identified a number of markers that reached strong GWA significance of p<1x10-5 and highlight, where available, putative links that may inform testable biological hypotheses regarding their candidature in the etiology of the ADHD+CP trait. It is now important to examine these markers in independent samples to investigate whether these represent true risk factors or strong examples of type I error.
Finally, this study examines the trait under the assumption that environmental risk factors are common to all individuals and all individuals have been exposed to risk at a level that is necessary for expression of the phenotype. This may be the case; however, recent approaches to examining externalizing behaviors have considered specific environmental exposures such as childhood maltreatment, parental substance use, pre-and peri-natal insult in the analytical model (Langley and others 2008) . Stratification of samples by exposure to environmental predictors of disease in the analytical model may create a more homogenous phenotype and consequently, improve our power to identify true genetic risk loci from GWAS data.
